Biogen

In News

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma - Reuters

Reuters - Apr 20, 2026

Biopharma bites: BMS axes more staff, Biogen's mAb deal, plus CAR-T data from Kyverna - FirstWord Pharma

FirstWord Pharma - Apr 20, 2026

Lightning Round: Biogen looks pretty darn good, says Jim Cramer - CNBC

CNBC - Apr 20, 2026

Merck partner reveals bispecific data; Biogen pays $100M for antibody rights - Endpoints News

Endpoints News - Apr 20, 2026

Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody - Fierce Biotech

Fierce Biotech - Apr 20, 2026

Biogen bullish on America with Durham Bulls team up - Fierce Pharma

Fierce Pharma - Apr 20, 2026

Notable analyst calls this week: Tesla, Qualcomm and Biogen among top picks - Seeking Alpha

Seeking Alpha - Apr 18, 2026

Biogen gets worldwide development and commercialization rights to felzartamab - The Pharma Letter

The Pharma Letter - Apr 21, 2026

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More - 24/7 Wall St.

24/7 Wall St. - Apr 14, 2026

Biogen gets FDA approval for higher dose of genetic disorder drug - Reuters

Reuters - Mar 30, 2026

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region - Biogen

Biogen - Apr 20, 2026

Biogen Inc. Secures Global Rights To Felzartamab Through Greater China Deal With TJ Biopharma - BioPharma APAC

BioPharma APAC - Apr 21, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment